Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRA-216 in Healthy Volunteers and Participants With Mild-to-Moderate Asthma
NCT07245368Phase 2Recruiting
- Sponsor
- Prana Therapies
- Start
- Nov 2025
- Primary completion
- Oct 2026
- Modality
- Biologic
- Countries
- 2
01
Overview
A Phase 2 trial of PRA-216 in asthma, sponsored by Prana Therapies. Started Nov 2025; status: recruiting.
02
Drugs
PRA-216
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07245368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245368.